Gabelli Funds LLC Makes New $3.31 Million Investment in Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS)

Gabelli Funds LLC bought a new position in Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 772,616 shares of the medical equipment provider’s stock, valued at approximately $3,307,000. Gabelli Funds LLC owned about 0.37% of Corindus Vascular Robotics as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently modified their holdings of the company. Havens Advisors LLC purchased a new position in Corindus Vascular Robotics in the third quarter worth about $1,455,000. JPMorgan Chase & Co. raised its holdings in shares of Corindus Vascular Robotics by 293.9% during the second quarter. JPMorgan Chase & Co. now owns 775,208 shares of the medical equipment provider’s stock valued at $2,326,000 after purchasing an additional 578,414 shares during the last quarter. ARP Americas LP purchased a new position in shares of Corindus Vascular Robotics during the third quarter valued at approximately $5,723,000. Menta Capital LLC purchased a new position in shares of Corindus Vascular Robotics during the second quarter valued at approximately $239,000. Finally, Tealwood Asset Management Inc. raised its holdings in shares of Corindus Vascular Robotics by 50.0% during the second quarter. Tealwood Asset Management Inc. now owns 15,000 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 5,000 shares during the last quarter.

Several research analysts have recently weighed in on the stock. Zacks Investment Research cut shares of Corindus Vascular Robotics from a “hold” rating to a “sell” rating in a report on Tuesday, August 13th. Cowen cut shares of Corindus Vascular Robotics from an “outperform” rating to a “market perform” rating and boosted their price objective for the company from $4.00 to $4.28 in a report on Thursday, August 8th.

Shares of CVRS remained flat at $$4.27 during mid-day trading on Friday. Corindus Vascular Robotics Inc has a 52 week low of $0.78 and a 52 week high of $4.40.

Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last released its quarterly earnings data on Thursday, August 8th. The medical equipment provider reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.01). The firm had revenue of $4.58 million for the quarter, compared to analysts’ expectations of $4.10 million.

Corindus Vascular Robotics Company Profile

Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures.

See Also: How does equity income fit into an investing strategy?

Institutional Ownership by Quarter for Corindus Vascular Robotics (NYSEAMERICAN:CVRS)

Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.